Clinical Implications of Prosthesis-Patient Mismatch and High Residual Gradients After AVR

Position 2: Echo Overestimates Bioprosthetic Valve Gradients Following TAVR. Always Confirm With Invasive Assessment

Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial

Considerations for Physiologic Testing to Assess CAD Severity in Patients With AS

Ascending Aorta Dilation & TAVR vs SAVR: When Should it Matter?

Case-Based Approach to Patients With Severe AS and MR (Degenerative and Functional)

Pharmacotherapy to Prevent Calcific Aortic Stenosis: Novel Targets and Novel Study Methodologies

Moderate AS With ‘At Risk Features: The EXPAND TAVR II Trial

Moderate AS With ‘At Risk’ Features: The PROGRESS Trial

Moderate AS With Heart Failure: TAVR UNLOAD